Billionaire Profile
A
Global Rank
#971

Image: Socit nationale d'acclimatation de France | Public domain | via Wikimedia Commons

Anne Beaufour

CEO, Pharmaceuticals
FRANCE
Real-Time Net Worth
$4.388B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
-0.12% (24h)
Age
62
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
FRANCE

Biography

Anne Beaufour is a prominent French businesswoman and heiress to the Ipsen pharmaceutical fortune. Born in 1963, she holds a degree in geology from the University of Paris-Sud. After completing her education, she joined the family business and quickly rose through the ranks, eventually becoming Chief Operating Officer. Her leadership, and strategic vision has been key to expanding Ipsen's global presence. As of July 9, 2024, her net worth is estimated at $2.8 billion. She is married to Michel Audibert and known for her philanthropic efforts.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Anne Gilberte Marie Beaufour was born on August 8, 1963, in Neuilly-sur-Seine, France. She is the daughter of Albert Beaufour and the granddaughter of Dr. Henri Beaufour, who founded the Beaufour laboratories in 1929, the predecessor to the global pharmaceutical company Ipsen. Growing up in a family deeply rooted in the pharmaceutical industry, Anne developed an early interest in business and science. She pursued her education at the University of Paris-Sud, earning a degree in geology.

Rise to Success

After graduating, Anne Beaufour joined the family business, Ipsen. She climbed the ranks and eventually served as the Chief Operating Officer. After her father's death in 2000, Anne and her brother Henri Beaufour inherited the majority of the family's 76% stake in Ipsen. Together, they control 57% of Ipsen. Under their leadership, Ipsen expanded its global reach, with products sold in over 115 countries.

Key Business Strategies

Anne Beaufour's strategic vision has been pivotal in steering Ipsen towards becoming a global leader in specialty pharmaceuticals. Her focus on innovation, quality, and patient-centricity has driven the company's growth. Ipsen's success is attributed to its research and development efforts, leading to innovative treatments. Anne and her brother Henri Beaufour are on the Board of Directors of Ipsen and Mayroy, the Ipsen controlling holding company.

Philanthropy

Anne Beaufour is known for her philanthropic efforts, supporting various charitable organizations, particularly in healthcare and education. She is also a passionate art collector.

Career Milestones

After graduation

Joined Ipsen

Began her career at the family-owned pharmaceutical company, Ipsen.

2000

Inherited Stake

Following her father's death, Anne and her brother inherited the majority stake in Ipsen.

2012

Businesswoman of the Year

Named "Businesswoman of the Year" by the French magazine Challenges.

Philanthropy & Social Impact

Healthcare and Education

Various charitable causes

Information not found

Supports healthcare and education initiatives.

Business Philosophy & Leadership

Leadership Principles

Innovation

Emphasis on research and development for innovative treatments.

Patient-centricity

Focusing on the needs of patients in developing treatments.